Literature DB >> 22539362

Effects of hypoxia and HIFs on cancer metabolism.

Vera Mucaj1, Jessica E S Shay, M Celeste Simon.   

Abstract

Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient availability. The hypoxia-inducible factors (HIFs) are a common link between adaptation to low O(2), changes in cancer metabolism, and malignant progression. The HIF-α subunits differentially regulate metabolic enzymes and other key factors involved in glycolysis, changes in redox status, and oxidative phosphorylation. Importantly, metabolic changes can, in turn, regulate HIF activity. Finally, changes in metabolism under hypoxia lead to important crosstalk between cancer cells and the stromal compartment of the microenvironment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539362     DOI: 10.1007/s12185-012-1070-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  45 in total

1.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

2.  Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein.

Authors:  M E Cockman; N Masson; D R Mole; P Jaakkola; G W Chang; S C Clifford; E R Maher; C W Pugh; P J Ratcliffe; P H Maxwell
Journal:  J Biol Chem       Date:  2000-08-18       Impact factor: 5.157

3.  Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis.

Authors:  Norihiko Takeda; Ellen L O'Dea; Andrew Doedens; Jung-whan Kim; Alexander Weidemann; Christian Stockmann; Masataka Asagiri; M Celeste Simon; Alexander Hoffmann; Randall S Johnson
Journal:  Genes Dev       Date:  2010-03-01       Impact factor: 11.361

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Substrate fate in activated macrophages: a comparison between innate, classic, and alternative activation.

Authors:  Juan-Carlos Rodríguez-Prados; Paqui G Través; Jimena Cuenca; Daniel Rico; Julián Aragonés; Paloma Martín-Sanz; Marta Cascante; Lisardo Boscá
Journal:  J Immunol       Date:  2010-05-24       Impact factor: 5.422

7.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia.

Authors:  Jung-whan Kim; Irina Tchernyshyov; Gregg L Semenza; Chi V Dang
Journal:  Cell Metab       Date:  2006-03       Impact factor: 27.287

8.  Kidney cancer: now available in a new flavor.

Authors:  William G Kaelin
Journal:  Cancer Cell       Date:  2008-12-09       Impact factor: 31.743

9.  Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells.

Authors:  Weibo Luo; Gregg L Semenza
Journal:  Oncotarget       Date:  2011-07

Review 10.  Biology of hypoxia-inducible factor-2alpha in development and disease.

Authors:  S A Patel; M C Simon
Journal:  Cell Death Differ       Date:  2008-02-15       Impact factor: 15.828

View more
  52 in total

1.  HIF-1α and GLUT-1 Expression in Atypical Endometrial Hyperplasia, Type I and II Endometrial Carcinoma: A Potential Role in Pathogenesis.

Authors:  Dalia Rifaat Al-Sharaky; Asmaa Gaber Abdou; Moshira Mohammed Abdel Wahed; Hend Abdou Kassem
Journal:  J Clin Diagn Res       Date:  2016-05-01

2.  Differential hypoxic regulation of the microRNA-146a/CXCR4 pathway in normal and leukemic monocytic cells: impact on response to chemotherapy.

Authors:  Isabella Spinello; Maria Teresa Quaranta; Rosa Paolillo; Elvira Pelosi; Anna Maria Cerio; Ernestina Saulle; Francesco Lo Coco; Ugo Testa; Catherine Labbaye
Journal:  Haematologica       Date:  2015-06-04       Impact factor: 9.941

3.  Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer.

Authors:  Jessica E S Shay; Hongxia Z Imtiyaz; Sharanya Sivanand; Amy C Durham; Nicolas Skuli; Sarah Hsu; Vera Mucaj; T S Karin Eisinger-Mathason; Bryan L Krock; Dionysios N Giannoukos; M Celeste Simon
Journal:  Carcinogenesis       Date:  2014-01-09       Impact factor: 4.944

4.  Radiofrequency ablation-induced upregulation of hypoxia-inducible factor-1α can be suppressed with adjuvant bortezomib or liposomal chemotherapy.

Authors:  Marwan Moussa; S Nahum Goldberg; Gaurav Kumar; Rupa R Sawant; Tatyana Levchenko; Vladimir Torchilin; Muneeb Ahmed
Journal:  J Vasc Interv Radiol       Date:  2014-10-16       Impact factor: 3.464

5.  The TIP60 Complex Is a Conserved Coactivator of HIF1A.

Authors:  Joel I Perez-Perri; Veronica L Dengler; K Audrey Audetat; Ahwan Pandey; Elizabeth A Bonner; Marjeta Urh; Jacqui Mendez; Danette L Daniels; Pablo Wappner; Matthew D Galbraith; Joaquín M Espinosa
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

Review 6.  Mitochondria and Cancer.

Authors:  Sejal Vyas; Elma Zaganjor; Marcia C Haigis
Journal:  Cell       Date:  2016-07-28       Impact factor: 41.582

Review 7.  Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy.

Authors:  Adam J Wolpaw; Chi V Dang
Journal:  Trends Cell Biol       Date:  2017-12-08       Impact factor: 20.808

8.  Hypoxia promotes the proliferation of cervical carcinoma cells through stimulating the secretion of IL-8.

Authors:  Li-Bing Liu; Feng Xie; Kai-Kai Chang; Ming-Qing Li; Yu-Han Meng; Xiao-Hui Wang; Hui Li; Da-Jin Li; Jin-Jin Yu
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 9.  New strategies to treat AML: novel insights into AML survival pathways and combination therapies.

Authors:  Ramya Nair; Alejandro Salinas-Illarena; Hanna-Mari Baldauf
Journal:  Leukemia       Date:  2020-10-29       Impact factor: 11.528

10.  Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism.

Authors:  Sarah-Maria Fendt; Eric L Bell; Mark A Keibler; Shawn M Davidson; Gregory J Wirth; Brian Fiske; Jared R Mayers; Matthias Schwab; Gary Bellinger; Alfredo Csibi; Akash Patnaik; Marie Jose Blouin; Lewis C Cantley; Leonard Guarente; John Blenis; Michael N Pollak; Aria F Olumi; Matthew G Vander Heiden; Gregory Stephanopoulos
Journal:  Cancer Res       Date:  2013-05-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.